BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22939305)

  • 1. Pharmacogenomics and the future of toxicology testing.
    Agrawal YP; Rennert H
    Clin Lab Med; 2012 Sep; 32(3):509-23. PubMed ID: 22939305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics: the inherited basis for interindividual differences in drug response.
    Evans WE; Johnson JA
    Annu Rev Genomics Hum Genet; 2001; 2():9-39. PubMed ID: 11701642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DMET microarray technology for pharmacogenomics-based personalized medicine.
    Burmester JK; Sedova M; Shapero MH; Mansfield E
    Methods Mol Biol; 2010; 632():99-124. PubMed ID: 20217574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How pharmacogenomics (PG) are changing practice: implications for prescribers, their patients, and the healthcare system (PG series part I).
    Preskorn SH; Hatt CR
    J Psychiatr Pract; 2013 Mar; 19(2):142-9. PubMed ID: 23507814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative and veterinary pharmacogenomics.
    Mosher CM; Court MH
    Handb Exp Pharmacol; 2010; (199):49-77. PubMed ID: 20204583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation and pharmacogenomics.
    Georgitsi M; Zukic B; Pavlovic S; Patrinos GP
    Pharmacogenomics; 2011 May; 12(5):655-73. PubMed ID: 21619428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging new technologies in Pharmacogenomics: rapid SNP detection, molecular dynamic simulation, and QSAR analysis methods to validate clinically important genetic variants of human ABC Transporter ABCB1 (P-gp/MDR1).
    Ishikawa T; Sakurai A; Hirano H; Lezhava A; Sakurai M; Hayashizaki Y
    Pharmacol Ther; 2010 Apr; 126(1):69-81. PubMed ID: 20138191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DrugBank and its relevance to pharmacogenomics.
    Wishart DS
    Pharmacogenomics; 2008 Aug; 9(8):1155-62. PubMed ID: 18681788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HapMap, pharmacogenomics, and the goal of personalized prescribing.
    O'Shaughnessy KM
    Br J Clin Pharmacol; 2006 Jun; 61(6):783-6. PubMed ID: 16722846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics in the assessment of therapeutic risks versus benefits: inside the United States Food and Drug Administration.
    Zineh I; Pacanowski MA
    Pharmacotherapy; 2011 Aug; 31(8):729-35. PubMed ID: 21923598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs.
    Phan VH; Tan C; Rittau A; Xu H; McLachlan AJ; Clarke SJ
    Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1395-410. PubMed ID: 21950349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics/genomics and personalized medicine.
    Sadée W; Dai Z
    Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental pharmacogenomics.
    Neville KA; Becker ML; Goldman JL; Kearns GL
    Paediatr Anaesth; 2011 Mar; 21(3):255-65. PubMed ID: 21320234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics and psychoactive drug therapy: ready for the patient?
    Steimer W
    Ther Drug Monit; 2010 Aug; 32(4):381-6. PubMed ID: 20526233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenomics: the quest for individualized therapy].
    López-López M; Guerrero-Camacho JL; Familiar-López IM; Jung-Cook H; Corona-Vázquez T; Alonso-Vilatela ME
    Rev Neurol; 2004 Dec 1-15; 39(11):1063-71. PubMed ID: 15597270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.